Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

作者: Romano Demicheli , Antonello Abbattista , Rosalba Miceli , Pinuccia Valagussa , Gianni Bonadonna

DOI: 10.1007/BF01807163

关键词:

摘要: Purpose To gather information on metastatic growth from the time-distribution of first treatment failure in breast cancer patients undergoing mastectomy alone.Methods: The risk recurrence at a given time after surgery was studied utilizing cause-specific hazard function. Recurrence categorized as any site, local-regional recurrence, distant metastases, and contralateral tumor. distribution assessed relative to tumor size, axillary lymph node involvement, menopausal status.Results: A total 1173 treated between 1964 1980 with alone no adjuvant therapy were studied. function for presented an early peak about 18 months surgery, second 60 then tapered plateau-like tail extending up 15 years. similar pattern detectable both local while curve tumors showed near flat plateau. recurrences much lower less than 2 cm diameter larger tumors; late small large primaries. Node-positive peaks four five times higher node-negative patients. Subdividing node-positive into 1–3 > 3 subsets did not substantially change general picture recurrence. functions premenopausal postmenopausal virtually superimposable.Conclusions: multipeak suggests that process resulting overt clinical metastases may have discrete features. Primary size could affect different ways status should be related level, pattern, does seem significantly distribution. Moreover, tumors, occurring constant throughout time, considered primary cancers. These findings reasonably explained by dormancy hypothesis, which assumes micrometastases biological steady states, most do imply growth. Tumor or microenvironment changes induce mean transition originate

参考文章(35)
P. Valagussa, C. Brambilla, M. Zambetti, G. Bonadonna, Salvage Treatments in Relapsing Resectable Breast Cancer Adjuvant Therapy of Primary Breast Cancer. ,vol. 115, pp. 69- 76 ,(1989) , 10.1007/978-3-642-83337-3_10
Ellen S. Vitetta, Richard D. May, Richard D. May, Jonathan W. Uhr, Thomas Tucker, Henry Siu, Cancer dormancy : studies of the murine BCL1 lymphoma Cancer Research. ,vol. 51, ,(1991)
E A Healey, E F Cook, E J Orav, S J Schnitt, J L Connolly, J R Harris, Contralateral breast cancer: clinical characteristics and impact on prognosis. Journal of Clinical Oncology. ,vol. 11, pp. 1545- 1552 ,(1993) , 10.1200/JCO.1993.11.8.1545
Charles L. Vogel, M. John Kennedy, Martin D. Abeloff, Management of locally recurrent breast cancer Cancer. ,vol. 71, pp. 2395- 2409 ,(1993) , 10.1002/1097-0142(19931001)72:7<2289::AID-CNCR2820720740>3.0.CO;2-P
JH Wijsman, CJ Cornelisse, R Keijzer, CJ van de Velde, JH van Dierendonck, A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy. British Journal of Cancer. ,vol. 64, pp. 463- 468 ,(1991) , 10.1038/BJC.1991.332
K. Pantel, G. Schlimok, S. Braun, D. Kutter, F. Lindemann, G. Schaller, I. Funke, J. R. Izbicki, G. Riethmuller, Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells Journal of the National Cancer Institute. ,vol. 85, pp. 1419- 1424 ,(1993) , 10.1093/JNCI/85.17.1419
Edmund A. Gehan, Estimating survival functions from the life table. Journal of Chronic Diseases. ,vol. 21, pp. 629- 644 ,(1969) , 10.1016/0021-9681(69)90035-6
Bernard Fisher, Madeline Bauer, D. Lawrence Wickerham, Carol K. Redmond, Edwin R. Fisher, Anatolio B. Cruz, Roger Foster, Bernard Gardner, Harvey Lerner, Richard Margolese, Roger Poisson, Henry Shibata, Herbert Volk, , Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer. ,vol. 52, pp. 1551- 1557 ,(1983) , 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3